Literature DB >> 32352234

Redefining fatty liver disease classification in 2020.

Luca Valenti1,2, Serena Pelusi2.   

Abstract

Entities:  

Keywords:  diabetes; fatty liver disease; genetics; metabolism; steatosis

Year:  2020        PMID： 32352234     DOI： 10.1111/liv.14430

Source DB:  PubMed          Journal:  Liver Int        ISSN： 1478-3223            Impact factor:   5.828


× No keyword cloud information.
  7 in total

Review 1.  Redefining non-alcoholic fatty liver disease to metabolic associated fatty liver disease: Is this plausible?

Authors:  Jalpa Devi; Aimun Raees; Amna Subhan Butt
Journal:  World J Hepatol       Date:  2022-01-27

2.  Associations Between GGT/HDL and MAFLD: A Cross-Sectional Study.

Authors:  Yuling Xing; Jinhu Chen; Jing Liu; Huijuan Ma
Journal:  Diabetes Metab Syndr Obes       Date:  2022-02-09       Impact factor: 3.168

3.  Metabolic-associated Fatty Liver Disease: Time to integrate ground-breaking new terminology to our clinical practice?

Authors:  Coskun Ozer Demirtas; Yusuf Yilmaz
Journal:  Hepatol Forum       Date:  2020-09-21

4.  MAFLD vs NAFLD: Let the contest begin!

Authors:  Cristiana Bianco; Stefano Romeo; Salvatore Petta; Michelle T Long; Luca Valenti
Journal:  Liver Int       Date:  2020-09       Impact factor: 8.754

5.  MAFLD in Obese Children: A Challenging Definition.

Authors:  Anna Di Sessa; Stefano Guarino; Giuseppina Rosaria Umano; Mattia Arenella; Salvatore Alfiero; Gaetano Quaranta; Emanuele Miraglia Del Giudice; Pierluigi Marzuillo
Journal:  Children (Basel)       Date:  2021-03-23

Review 6.  Is HSD17B13 Genetic Variant a Protector for Liver Dysfunction? Future Perspective as a Potential Therapeutic Target.

Authors:  Takashi Motomura; Sriram Amirneni; Ricardo Diaz-Aragon; Lanuza A P Faccioli; Michelle R Malizio; Michael C Coard; Zehra N Kocas-Kilicarslan; Carla Frau; Nils Haep; Alina Ostrowska; Rodrigo M Florentino; Alejandro Soto-Gutierrez
Journal:  J Pers Med       Date:  2021-06-30

7.  MAFLD Criteria May Overlook a Subtype of Patient with Steatohepatitis and Significant Fibrosis.

Authors:  Jiaofeng Huang; Wenjuan Xue; Mingfang Wang; Yinlian Wu; Medha Singh; Yueyong Zhu; Rahul Kumar; Su Lin
Journal:  Diabetes Metab Syndr Obes       Date:  2021-07-27       Impact factor: 3.168
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.